Back

Effects of serelaxin on a systolic cardiac dysfunction induced by isoproterenol in mice with increased cardiac aldosterone

21 May 2016 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Novel drugs - how do they work? Animal models and experimentation HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Gilles Billebeau

Hospital Lariboisiere, Paris (France)

5 More presentations in this session

Presentation thumbnail
Novel drugs in heart failure: what's on the horizon?
Professor C. Maack (Wuerzburg, DE)
Slides Video
Presentation thumbnail
Why treatment with natriuretic peptide analogs failed to fulfill our expectations? - receptor expression and function in a failing heart.
Doctor K. Kodziszewska (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
ORM-3819 promotes cardiac contractility on a dual mechanism of action: troponin-C dependent calcium sensitization is supported by selective PDE III inhibition
Doctor L. Nagy (Debrecen, HU)
Abstract
Presentation thumbnail
Vepoloxamer (purified poloxamer-188) improves LV function, limits cardiomyocyte calcium overload and restores integrity of calciu cycling proteins in myocardium of dogs with advanced heart failure
Professor H. Sabbah (Detroit, US)
Abstract Slides Video
Presentation thumbnail
Targeting HDACs in heart failure.

Access the full session

Session thumbnail
Novel drugs - how do they work?

The Event

Event poster

HEART FAILURE 2016

21 May 2016 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-acting CRF2 peptide agonist improves cardiac function in a rat heart failure model
28 August 2023
thumbnail
Congress Presentation
Sympathetic nervous system hyperactivity induces cardiac dysfunction and remodeling in mice: role of the NADPH oxidase/SGLT 1 and 2 pathways
29 June 2021
thumbnail
Congress Presentation
Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study
22 May 2023
thumbnail
Congress Presentation
Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources